This episode examines the barriers to accessing HER2-targeted therapies for non-small cell lung cancer (NSCLC) and strategies ...

Vishal A. Patel, MD, explains that delayed skin cancer diagnoses contribute to more advanced disease and poorer outcomes in ...

PBM reforms, Medicare Advantage trends, TrumpRx launch, and Express Scripts settlement highlight key shifts in drug pricing, ...

Vishal A. Patel, MD, is an associate professor of dermatology at the GW School of Medicine & Health Sciences and the director ...

Multiple myeloma was once viewed as an incurable diagnosis, but Ameet Patel, MD, of Florida Cancer Specialists & Research ...

MicroRNAs are central regulators of DLBCL biology and show strong potential as minimally invasive biomarkers to improve ...

Experts discuss the importance of transitioning cancer care from academic centers to community settings, ensuring effective ...

Experts discuss the importance of transitioning cancer care from academic centers to community practices, ensuring patient ...

Panelist and director of the leukemia program at Massachusetts General Hospital, Amir Fathi, MD, explained that catchment ...

A universal policy providing free prescription drugs to seniors in Poland significantly reduced out-of-pocket spending and sharply lowered the risk of catastrophic health expenditures, but it may also ...

With medically integrated dispensing (MID) models, pharmacists are more embedded in care and engage more frequently with patients, according to Kenneth Komorny, PharmD, BCPS, of Moffitt Cancer Center.

Osama Abdelghany, PharmD, explains how medically integrated dispensing improves oncology workflows, patient access, and outcomes through EMR-driven care. Medically integrated dispensing (MID) has the ...